{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:32:08Z","timestamp":1770204728673,"version":"3.49.0"},"reference-count":363,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007905","name":"College of Liberal Arts, Texas A and M University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pnpbp.2019.02.010","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T02:04:24Z","timestamp":1550455464000},"page":"428-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Members of the same pharmacological family are not alike: Different opioids, different consequences, hope for the opioid crisis?"],"prefix":"10.1016","volume":"92","author":[{"given":"Michael A.","family":"Emery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshana","family":"Eitan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JCP.0000000000000344","article-title":"Serotonin syndrome: analysis of cases registered in the French pharmacovigilance database","volume":"35","author":"Abadie","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2019.02.010_bb0010","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/00001756-200006260-00029","article-title":"Immunohistochemical localization of the carboxy terminus of the novel mu opioid receptor splice variant MOR-1C within the human spinal cord","volume":"11","author":"Abbadie","year":"2000","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0306-4522(00)00248-7","article-title":"Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS","volume":"100","author":"Abbadie","year":"2000","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R","article-title":"Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: evidence for region-specific processing","volume":"419","author":"Abbadie","year":"2000","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3565(25)20227-0","article-title":"Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice","volume":"258","author":"Abdelhamid","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sc.2016.28","article-title":"Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury","volume":"54","author":"Aceves","year":"2016","journal-title":"Spinal Cord"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0035","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1089\/neu.2016.4601","article-title":"Nor-Binaltorphimine blocks the adverse effects of morphine after spinal cord injury","volume":"34","author":"Aceves","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"34","key":"10.1016\/j.pnpbp.2019.02.010_bb0040","doi-asserted-by":"crossref","first-page":"35518","DOI":"10.1074\/jbc.M405878200","article-title":"Differential kinetic and spatial patterns of Beta-Arrestin and G protein-mediated ERK activation by the angiotensin II receptor","volume":"279","author":"Ahn","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12991-018-0192-4","article-title":"The frequency of DRD2 rs1076560 and OPRM1 rs1799971 in substance use disorder patients from the United Arab Emirates","volume":"17","author":"Alblooshi","year":"2018","journal-title":"Ann. General Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"issue":"280","key":"10.1016\/j.pnpbp.2019.02.010_bb0055","article-title":"Opioid receptor desensitization: mechanisms and its link to tolerance","volume":"5","author":"Allouche","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0060","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/0269881116689257","article-title":"Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents","volume":"31","author":"Altarifi","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0896-6273(01)00530-X","article-title":"A RAVE about opioid withdrawal","volume":"32","author":"Alvarez","year":"2001","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","article-title":"Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","volume":"33","author":"Arner","year":"1988","journal-title":"Pain"},{"issue":"15","key":"10.1016\/j.pnpbp.2019.02.010_bb0075","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1523\/JNEUROSCI.0303-06.2006","article-title":"Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures","volume":"26","author":"Arttamangkul","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cell.2012.09.003","article-title":"Restructuring G-protein-coupled receptor activation","volume":"151","author":"Audet","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2012.07.018","article-title":"Effects of peripheral kappa opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats","volume":"524","author":"Auh","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2018.08.002","article-title":"The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats","volume":"192","author":"Austin Zamarripa","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"35","key":"10.1016\/j.pnpbp.2019.02.010_bb0095","doi-asserted-by":"crossref","first-page":"21309","DOI":"10.1074\/jbc.271.35.21309","article-title":"Chronic opioid treatment induces adenylyl cyclase V superactivation: involvement of G\u03b2\u03b3","volume":"271","author":"Avidor-Reiss","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0100","series-title":"Pharmacology","first-page":"131","article-title":"Drug metabolism","author":"Bachmann","year":"2009"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13065-018-0383-8","article-title":"Better agonist for the opioid receptors","volume":"12","author":"Badshah","year":"2018","journal-title":"Chem. Cent. J."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0110","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s12264-014-1483-7","article-title":"Toll-like receptor 4-mediated nuclear factor-\u03baB activation in spinal cord contributes to chronic morphine-induced analgesic tolerance and hyperalgesia in rats","volume":"30","author":"Bai","year":"2014","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1476-5381.2009.00140.x","article-title":"Involvement of PKC\u03b1 and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of \u03bc-opioid receptors in mature brain neurons","volume":"158","author":"Bailey","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0310057X1204000204","article-title":"Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two","volume":"40","author":"Baldo","year":"2012","journal-title":"Anaesth. Intensive Care"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(25)10296-6","article-title":"Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats","volume":"264","author":"Bals-Kubik","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/WNR.0b013e328363fde8","article-title":"Gabapentin attenuates morphine tolerance through interleukin-10","volume":"25","author":"Bao","year":"2014","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00210-014-1056-3","article-title":"Effects of opioids on human serotonin transporters","volume":"388","author":"Barann","year":"2015","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.drugalcdep.2013.07.016","article-title":"Differential effects of methadone and buprenorphine on the response of D2\/D3 dopamine receptors in adolescent mice","volume":"132","author":"Barwatt","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/\u03b2-Arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0150","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","article-title":"Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo","volume":"27","author":"Beaulieu","year":"2007","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0155","first-page":"492","article-title":"Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period","volume":"82","author":"Beilin","year":"1996","journal-title":"Anesth. Analg."},{"issue":"30","key":"10.1016\/j.pnpbp.2019.02.010_bb0160","doi-asserted-by":"crossref","first-page":"27662","DOI":"10.1074\/jbc.M502593200","article-title":"Mu and kappa opioid receptors activate ERK\/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes","volume":"280","author":"Belcheva","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/jpet.110.177493","article-title":"Regulation of kappa-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo","volume":"338","author":"Berg","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0170","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/mol.111.072702","article-title":"Allosteric interactions between \u03b4 and \u03ba opioid receptors in peripheral sensory neurons","volume":"81","author":"Berg","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0175","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.neuroscience.2013.05.018","article-title":"Tissue plasminogen activator contributes to morphine tolerance and induces mechanical allodynia via astrocytic IL-1\u03b2 and ERK signaling in the spinal cord of mice","volume":"247","author":"Berta","year":"2013","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1471-4159.2009.06308.x","article-title":"Supraspinal G\u03b2\u03b3-dependent stimulation of PLC\u03b2 originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia","volume":"111","author":"Bianchi","year":"2009","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.02.010_bb0185","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/014107689608900711","article-title":"The D2 dopamine receptor gene as a determinant of reward deficiency syndrome","volume":"89","author":"Blum","year":"1996","journal-title":"J. R. Soc. Med."},{"issue":"5449","key":"10.1016\/j.pnpbp.2019.02.010_bb0190","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking \u03b2-Arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"issue":"5772","key":"10.1016\/j.pnpbp.2019.02.010_bb0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.1120378","article-title":"Differential targeting of G\u03b2\u03b3-subunit signaling with small molecules","volume":"312","author":"Bonacci","year":"2006","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.pnpbp.2019.02.010_bb0200","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/0024-3205(81)90519-1","article-title":"Heroin reward is dependent on a dopaminergic substrate","volume":"29","author":"Bozarth","year":"1981","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb0205","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.celrep.2016.07.084","article-title":"GRK2 constitutively governs peripheral delta opioid receptor activity","volume":"16","author":"Brackley","year":"2016","journal-title":"Cell Rep."},{"issue":"21","key":"10.1016\/j.pnpbp.2019.02.010_bb0210","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1074\/jbc.M117.776799","article-title":"Identification of a signaling cascade that maintains constitutive delta-opioid receptor incompetence in peripheral sensory neurons","volume":"292","author":"Brackley","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb0215","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1176\/appi.ajp.162.8.1483","article-title":"Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress","volume":"162","author":"Brady","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.02.010_bb0220","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archpsyc.59.11.1039","article-title":"Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders","volume":"59","author":"Brook","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","article-title":"Kinase cascades and ligand-directed signaling at the kappa opioid receptor","volume":"210","author":"Bruchas","year":"2010","journal-title":"Psychopharmacology"},{"issue":"26","key":"10.1016\/j.pnpbp.2019.02.010_bb0235","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1074\/jbc.M513640200","article-title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","volume":"281","author":"Bruchas","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"456","key":"10.1016\/j.pnpbp.2019.02.010_bb0240","doi-asserted-by":"crossref","first-page":"ra117","DOI":"10.1126\/scisignal.aai8441","article-title":"Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria","volume":"9","author":"Brust","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0245","first-page":"190","article-title":"Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders","volume":"6","author":"Butelman","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0250","series-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics","article-title":"Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination","author":"Buxton","year":"2011"},{"issue":"253","key":"10.1016\/j.pnpbp.2019.02.010_bb0255","article-title":"Does the kappa opioid receptor system contribute to pain aversion?","volume":"5","author":"Cahill","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb0260","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1523\/JNEUROSCI.20-05-01849.2000","article-title":"Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D2 dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats","volume":"20","author":"Cai","year":"2000","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000172","article-title":"Persistent cAMP-signals triggered by internalized G-protein-coupled receptors","volume":"7","author":"Calebiro","year":"2009","journal-title":"PLoS Biol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0270","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bjp.0700995","article-title":"Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum","volume":"120","author":"Capasso","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0275","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.pnpbp.2019.02.010_bb0280","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1073\/pnas.90.9.4062","article-title":"Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain","volume":"90","author":"Carter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0285","author":"Center for Medicare and Medicaid Services"},{"issue":"46","key":"10.1016\/j.pnpbp.2019.02.010_bb0290","doi-asserted-by":"crossref","first-page":"20115","DOI":"10.1073\/pnas.1009923107","article-title":"Formation of mu-\/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia","volume":"107","author":"Chakrabarti","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0295","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/jnc.13519","article-title":"Selective up-regulation of functional mu-opioid receptor splice variants by chronic opioids","volume":"136","author":"Chakrabarti","year":"2016","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0300","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3565(25)22079-1","article-title":"Potent morphiceptin analogs: structure activity relationships and morphine-like activities","volume":"227","author":"Chang","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0305","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The therapeutic potential of \u03ba-opioids for treatment of pain and addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb0310","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.febslet.2008.01.028","article-title":"D2\/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways","volume":"582","author":"Chen","year":"2008","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jnc.12071","article-title":"Identification of phosphorylation sites in the COOH-terminal tail of the \u03bc-opioid receptor","volume":"124","author":"Chen","year":"2013","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0320","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuropharm.2009.06.034","article-title":"Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey","volume":"57","author":"Chieng","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0325","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.37.1.167","article-title":"G protein \u03b2\u03b3 subunits","volume":"37","author":"Clapham","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ahg.12046","article-title":"The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction","volume":"78","author":"Clarke","year":"2014","journal-title":"Ann. Hum. Genet."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0335","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0022-3565(25)10630-7","article-title":"Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception","volume":"274","author":"Codd","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0340","first-page":"73","article-title":"The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268)","volume":"26","author":"Coffman","year":"1998","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0345","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pharmthera.2012.01.008","article-title":"Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence","volume":"134","author":"Coller","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0350","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3565(25)39544-3","article-title":"Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice","volume":"267","author":"Comer","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0355","author":"Wikimedia Commons"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2019.02.010_bb0360","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2004.03.056","article-title":"No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse","volume":"492","author":"Contet","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0365","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)38234-5","article-title":"d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia","volume":"289","author":"Davis","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"15","key":"10.1016\/j.pnpbp.2019.02.010_bb0370","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1016\/S0021-9258(20)79672-9","article-title":"A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor","volume":"255","author":"De Lean","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0375","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"\u03b2-arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0380","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"14","key":"10.1016\/j.pnpbp.2019.02.010_bb0385","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0390","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1476-5381.2011.01382.x","article-title":"Agonist-selective patterns of mu-opioid receptor phosphorylation revealed by phosphosite-specific antibodies","volume":"164","author":"Doll","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0395","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1476-5381.2012.02080.x","article-title":"Deciphering mu-opioid receptor phosphorylation and dephosphorylation in HEK293 cells","volume":"167","author":"Doll","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0400","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0960-5428(06)80057-4","article-title":"Neuroimmunomodulation by opiates: relationship to HIV-1 infection and AIDS","volume":"3","author":"Donahoe","year":"1993","journal-title":"Adv. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.02.010_bb0405","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-827X(01)01020-5","article-title":"Selective delta opioid receptor agonists for inflammatory and neuropathic pain","volume":"56","author":"Dondio","year":"2001","journal-title":"Farmaco"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-pharmtox-061008-103038","article-title":"The role of G\u03b2\u03b3 subunits in the organization, assembly, and function of GPCR signaling complexes","volume":"49","author":"Dupre","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"37","key":"10.1016\/j.pnpbp.2019.02.010_bb0415","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1523\/JNEUROSCI.2444-15.2015","article-title":"Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons","volume":"35","author":"Ehrich","year":"2015","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.02.010_bb0420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-5728(97)00219-1","article-title":"Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations","volume":"83","author":"Eisenstein","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0425","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbr.2015.01.023","article-title":"Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2\/D3 dopamine receptors","volume":"284","author":"Emery","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb0430","first-page":"908","article-title":"Differential effects of oxycodone, hydrocodone, and morphine on activation levels of signaling molecules","volume":"17","author":"Emery","year":"2016","journal-title":"Pain Med."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071980","article-title":"The beta-blocker Nebivolol is a GRK\/\u03b2-Arrestin biased agonist","volume":"8","author":"Erickson","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0440","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2011.02.074","article-title":"Morphine sensitization increases the extracellular level of glutamate in CA1 of rat hippocampus via mu-opioid receptor","volume":"494","author":"Farahmandfar","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0445","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/10550887.2013.795467","article-title":"Comorbid posttraumatic stress disorder and opiate addiction: a literature review","volume":"32","author":"Fareed","year":"2013","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0450","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jad.2018.04.058","article-title":"The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: a cross-sectional study","volume":"235","author":"Feingold","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0455","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nn.3295","article-title":"Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl(\u2212) homeostasis","volume":"16","author":"Ferrini","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0460","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","article-title":"Understanding opioid reward","volume":"38","author":"Fields","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0465","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.psychres.2016.06.053","article-title":"Depression - A major but neglected consequence contributing to the health toll from prescription opioids?","volume":"243","author":"Fischer","year":"2016","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb0470","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2174\/092986706776360851","article-title":"Rational drug design of selective epsilon opioid receptor agonist TAN-821 and antagonist TAN-1014","volume":"13","author":"Fujii","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"18","key":"10.1016\/j.pnpbp.2019.02.010_bb0475","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1111\/bph.12798","article-title":"Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10","volume":"171","author":"Fujita","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0480","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bph.12663","article-title":"Heteromers of \u03bc-\u03b4 opioid receptors: new pharmacology and novel therapeutic possibilities","volume":"172","author":"Fujita","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0485","series-title":"Miller's Anesthesia","first-page":"864","article-title":"Opioid analgesics","author":"Fukuda","year":"2015"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.02.010_bb0490","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0028-3908(93)90026-Y","article-title":"Blockade of morphine reward through the activation of kappa-opioid receptors in mice","volume":"32","author":"Funada","year":"1993","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0495","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.schres.2014.07.040","article-title":"Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia","volume":"159","author":"Funk","year":"2014","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb0500","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2007.06.005","article-title":"The evasive nature of drug efficacy: implications for drug discovery","volume":"28","author":"Galandrin","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.02.010_bb0505","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/omi.2017.0057","article-title":"Contribution of genetic polymorphisms and haplotypes in DRD2, BDNF, and opioid receptors to heroin dependence and endophenotypes among the Han Chinese","volume":"21","author":"Gao","year":"2017","journal-title":"OMICS"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0510","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050490","article-title":"Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys","volume":"135","author":"Gatch","year":"1998","journal-title":"Psychopharmacology"},{"issue":"5\u20136","key":"10.1016\/j.pnpbp.2019.02.010_bb0515","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/FBP.0b013e32834a1f2c","article-title":"Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches","volume":"22","author":"Gav\u00e9riaux-Ruff","year":"2011","journal-title":"Behav. Pharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2019.02.010_bb0520","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1073\/pnas.95.11.6326","article-title":"Abolition of morphine-immunosuppression in mice lacking the \u03bc-opioid receptor gene","volume":"95","author":"Gav\u00e9riaux-Ruff","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb0525","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1111\/j.1460-9568.2008.06223.x","article-title":"Inflammatory pain is enhanced in delta opioid receptor-knockout mice","volume":"27","author":"Gaveriaux-Ruff","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0530","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.pain.2010.12.031","article-title":"Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia","volume":"152","author":"Gaveriaux-Ruff","year":"2011","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.02.010_bb0535","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm1196-1248","article-title":"Kappa-opioids produce significantly greater analgesia in women than in men","volume":"2","author":"Gear","year":"1996","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0540","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0304-3959(99)00119-0","article-title":"The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain","volume":"83","author":"Gear","year":"1999","journal-title":"Pain"},{"issue":"26","key":"10.1016\/j.pnpbp.2019.02.010_bb0545","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1523\/JNEUROSCI.0731-14.2015","article-title":"Pronociceptive and antinociceptive effects of buprenorphine in the spinal cord dorsal horn cover a dose range of four orders of magnitude","volume":"35","author":"Gerhold","year":"2015","journal-title":"J. Neurosci."},{"issue":"16","key":"10.1016\/j.pnpbp.2019.02.010_bb0550","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1074\/jbc.M513380200","article-title":"Distinct \u03b2-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1\/2 activation","volume":"281","author":"Gesty-Palmer","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0555","first-page":"69","article-title":"Relationship of opioid dependence and positive and negative symptoms in schizophrenic patients","volume":"1","author":"Ghaffarinejad","year":"2009","journal-title":"Addict. Health"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0560","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","article-title":"Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity","volume":"95","author":"Gillman","year":"2005","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/PMC.S3898","article-title":"Stereochemical basis for a unified structure activity theory of aromatic and heterocyclic rings in selected opioids and opioid peptides","volume":"4","author":"Goldberg","year":"2010","journal-title":"Perspect. Medicin. Chem."},{"issue":"29","key":"10.1016\/j.pnpbp.2019.02.010_bb0570","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.1222044110","article-title":"Identification of a mu-delta opioid receptor heteromer-biased agonist with antinociceptive activity","volume":"110","author":"Gomes","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0575","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0580","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","article-title":"The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord","volume":"223","author":"Gorman","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb0585","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0590","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-006-0365-8","article-title":"Development of tolerance and sensitization to different opioid agonists in rats","volume":"186","author":"Grecksch","year":"2006","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0595","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1568010023344869","article-title":"The immunosuppressive activity of proinflammatory cytokines in experimental models: potential for therapeutic intervention in autoimmunity","volume":"1","author":"Grohmann","year":"2002","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0600","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2009.10.013","article-title":"NMDA receptors are involved in upstream of the spinal JNK activation in morphine antinociceptive tolerance","volume":"467","author":"Guo","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"131","key":"10.1016\/j.pnpbp.2019.02.010_bb0605","doi-asserted-by":"crossref","first-page":"ra54","DOI":"10.1126\/scisignal.2000807","article-title":"Increased abundance of opioid receptor heteromers after chronic morphine administration","volume":"3","author":"Gupta","year":"2010","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0610","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: more than just kinases and not only for GPCRs","volume":"133","author":"Gurevich","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"6493","key":"10.1016\/j.pnpbp.2019.02.010_bb0615","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/371155a0","article-title":"Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome","volume":"371","author":"Harris","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0620","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuropharm.2008.06.050","article-title":"Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse","volume":"56","author":"Haydon","year":"2009","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0625","doi-asserted-by":"crossref","first-page":"219","DOI":"10.15288\/jsa.1988.49.219","article-title":"The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment","volume":"49","author":"Helzer","year":"1988","journal-title":"J. Stud. Alcohol"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0630","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0022-3565(25)39585-6","article-title":"Immunosuppression by morphine is mediated by central pathways","volume":"267","author":"Hernandez","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb0635","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1177\/0269881112443741","article-title":"Morphine alters the locomotor responses to a D2\/D3 dopamine receptor agonist differentially in adolescent and adult mice","volume":"26","author":"Hofford","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0640","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbr.2007.02.035","article-title":"The impact of morphine after a spinal cord injury","volume":"179","author":"Hook","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb0645","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/neu.2008.0710","article-title":"Intrathecal morphine attenuates recovery of function after a spinal cord injury","volume":"26","author":"Hook","year":"2009","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0650","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1089\/neu.2016.4507","article-title":"Neurobiological effects of morphine after spinal cord injury","volume":"34","author":"Hook","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb0655","doi-asserted-by":"crossref","first-page":"C856","DOI":"10.1152\/ajpcell.1999.277.5.C856","article-title":"What molecular events underlie heterologous desensitization? Focus on \u201cReceptor phosphorylation does not mediate cross talk between muscarinic M3 and bradykinin B2 receptors\u201d","volume":"277","author":"Hosey","year":"1999","journal-title":"Am. J. Phys. Cell Physiol."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0660","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/med.2610090306","article-title":"Recent developments in the design of receptor specific opioid peptides","volume":"9","author":"Hruby","year":"1989","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0665","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into \u03bc-opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0670","doi-asserted-by":"crossref","first-page":"1), 1","DOI":"10.1124\/mol.109.060251","article-title":"Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor","volume":"77","author":"Hudson","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0675","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/dnares\/7.2.111","article-title":"Genomic characterization of the human heterotrimeric G Protein \u03b1, \u03b2, and \u03b3 subunit genes","volume":"7","author":"Hurowitz","year":"2000","journal-title":"DNA Res."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0680","doi-asserted-by":"crossref","DOI":"10.1100\/tsw.2007.230","article-title":"Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward","volume":"7","author":"Hutchinson","year":"2007","journal-title":"Sci. World J."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb0685","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbi.2008.05.004","article-title":"Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb0690","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbi.2008.07.008","article-title":"Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0695","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","article-title":"Evidence that opioids may have toll-like receptor 4 and MD-2 effects","volume":"24","author":"Hutchinson","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"33","key":"10.1016\/j.pnpbp.2019.02.010_bb0700","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","article-title":"Opioid activation of toll-like receptor 4 contributes to drug reinforcement","volume":"32","author":"Hutchinson","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb0705","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/bph.12546","article-title":"Heterologous regulation of agonist-independent mu-opioid receptor phosphorylation by protein kinase C","volume":"171","author":"Illing","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"7\u20138","key":"10.1016\/j.pnpbp.2019.02.010_bb0710","first-page":"435","article-title":"Pharmacology of methadone and its isomers","volume":"71","author":"Inturrisi","year":"2005","journal-title":"Minerva Anestesiol."},{"issue":"7442","key":"10.1016\/j.pnpbp.2019.02.010_bb0715","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature12000","article-title":"Conformational biosensors reveal GPCR signalling from endosomes","volume":"495","author":"Irannejad","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pnpbp.2019.02.010_bb0720","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0192-0561(99)00025-9","article-title":"Effects of fentanyl on cellular immune functions in man","volume":"21","author":"Jacobs","year":"1999","journal-title":"Int. J. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0725","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/mol.117.109975","article-title":"Allosterism within delta opioid-kappa opioid receptor heteromers in peripheral sensory neurons: regulation of kappa opioid agonist efficacy","volume":"93","author":"Jacobs","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0730","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.115.225896","article-title":"Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons","volume":"355","author":"Jamshidi","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0735","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0301-0082(03)00085-6","article-title":"Dopamine: a potential substrate for synaptic plasticity and memory mechanisms","volume":"69","author":"Jay","year":"2003","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.02.010_bb0740","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ejp.617","article-title":"Selective suppression of microglial activation by paeoniflorin attenuates morphine tolerance","volume":"19","author":"Jiang","year":"2015","journal-title":"Eur. J. Pain"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.02.010_bb0745","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugalcdep.2010.11.005","article-title":"Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum","volume":"115","author":"Johnson","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0750","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/mol.112.082875","article-title":"Differentiation of opioid drug effects by hierarchical multi-site phosphorylation","volume":"83","author":"Just","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0755","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1471-4159.2004.02338.x","article-title":"Phosphatidylinositol-3 kinase is distinctively required for mu-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase","volume":"89","author":"Kam","year":"2004","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0760","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0028-3908(95)00189-1","article-title":"Involvement of dopamine D2 receptor-mediated functions in the modulation of morphine-induced antinociception in diabetic mouse","volume":"35","author":"Kamei","year":"1996","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0765","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11481-011-9314-3","article-title":"Influence of endogenous opioid systems on T lymphocytes as assessed by the knockout of mu, delta and kappa opioid receptors","volume":"6","author":"Karaji","year":"2011","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"5692","key":"10.1016\/j.pnpbp.2019.02.010_bb0770","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.02.010_bb0775","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.22-09-03306.2002","article-title":"The neuroscience of natural rewards: relevance to addictive drugs","volume":"22","author":"Kelley","year":"2002","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0780","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0785","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0790","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.108.000992","article-title":"Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery","volume":"62","author":"Kenakin","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0795","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1037\/h0080151","article-title":"The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization","volume":"66","author":"Kessler","year":"1996","journal-title":"Am. J. Orthop."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0800","doi-asserted-by":"crossref","DOI":"10.1038\/srep11389","article-title":"Morphine modulates interleukin-4- or breast cancer cell-induced pro-metastatic activation of macrophages","volume":"5","author":"Khabbazi","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0805","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/pr.111.005603","article-title":"The expanding roles of G\u03b2\u03b3 subunits in G protein\u2013coupled receptor signaling and drug action","volume":"65","author":"Khan","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0810","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nature19424","article-title":"Designing the ideal opioid","volume":"537","author":"Kieffer","year":"2016","journal-title":"Nature"},{"issue":"40","key":"10.1016\/j.pnpbp.2019.02.010_bb0815","doi-asserted-by":"crossref","first-page":"37409","DOI":"10.1074\/jbc.M106728200","article-title":"Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb0820","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0028-3908(01)00100-9","article-title":"Synergistic \u03bc-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons","volume":"41","author":"Kishimoto","year":"2001","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0825","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2007.10.003","article-title":"Role of receptor internalization in opioid tolerance and dependence","volume":"117","author":"Koch","year":"2008","journal-title":"Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.pnpbp.2019.02.010_bb0830","doi-asserted-by":"crossref","first-page":"13652","DOI":"10.1074\/jbc.273.22.13652","article-title":"Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization","volume":"273","author":"Koch","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.pnpbp.2019.02.010_bb0835","doi-asserted-by":"crossref","first-page":"31408","DOI":"10.1074\/jbc.M100305200","article-title":"C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization","volume":"276","author":"Koch","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0840","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1471-4159.2003.02189.x","article-title":"Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization","volume":"88","author":"Koch","year":"2004","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0845","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/mol.104.004994","article-title":"Receptor endocytosis counteracts the development of opioid tolerance","volume":"67","author":"Koch","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0850","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-2999(96)00520-1","article-title":"Peripheral \u03ba1-opioid receptor-mediated analgesia in mice","volume":"310","author":"Kolesnikov","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0855","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.1992.tb25966.x","article-title":"Neural mechanisms of drug reinforcement","volume":"654","author":"Koob","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0860","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2015.08.027","article-title":"Inhibition of microglia in the basolateral amygdala enhanced morphine-induced antinociception: possible role of GABAA receptors","volume":"765","author":"Kosarmadar","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0865","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1476-5381.1980.tb10422.x","article-title":"Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with \u03bc- and \u03b4-receptors","volume":"68","author":"Kosterlitz","year":"1980","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0870","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J. Neurosci."},{"issue":"45","key":"10.1016\/j.pnpbp.2019.02.010_bb0875","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0910705106","article-title":"Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking","volume":"106","author":"Land","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.pnpbp.2019.02.010_bb6000","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1021\/jm040894o","article-title":"Synthesis and biological evaluation of 14-alkoxymorphinans. 22. Influence of the 14-alkoxy group and the substitution in position 5 in 14-alkoxymorphinan-6-ones on in vitro and in vivo activities","volume":"48","author":"Lattanzi","year":"2005","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0880","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/mol.58.2.388","article-title":"Receptor density and recycling affect the rate of agonist-induced desensitization of mu-opioid receptor","volume":"58","author":"Law","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0885","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.pain.2010.09.018","article-title":"Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia","volume":"151","author":"Lawson","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0890","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neulet.2014.11.003","article-title":"Rosuvastatin attenuated the existing morphine tolerance in rats with L5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42\/44","volume":"584","author":"Li","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0895","first-page":"5","article-title":"Opioid system modulates the immune function: a review","volume":"1","author":"Liang","year":"2016","journal-title":"Transl. Perioper. Pain Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0900","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11302-016-9525-4","article-title":"Morphine enhances IL-1\u03b2 release through toll-like receptor 4-mediated endocytic pathway in microglia","volume":"12","author":"Liang","year":"2016","journal-title":"Purinergic Signal"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0905","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11596-006-0427-5","article-title":"Effects of morphine, fentanyl and tramadol on human immune response","volume":"26","author":"Liu","year":"2006","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0910","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuropharm.2015.03.037","article-title":"Prefrontal cortex gates acute morphine action on dopamine neurons in the ventral tegmental area","volume":"95","author":"Liu","year":"2015","journal-title":"Neuropharmacology"},{"issue":"Pt 4","key":"10.1016\/j.pnpbp.2019.02.010_bb0915","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/brain\/awl384","article-title":"Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors","volume":"130","author":"Loacker","year":"2007","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0920","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0306-4522(97)00327-8","article-title":"Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens","volume":"82","author":"Lu","year":"1998","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb0925","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.1998.71030980.x","article-title":"D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP\/JNK pathways in rat C6-D2L glioma cells","volume":"71","author":"Luo","year":"1998","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb0930","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0935","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1242\/jcs.03338","article-title":"\u03b2-arrestin signaling and regulation of transcription","volume":"120","author":"Ma","year":"2007","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0940","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/j.1476-5381.2011.01552.x","article-title":"Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins","volume":"165","author":"Magalhaes","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb0945","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6642","key":"10.1016\/j.pnpbp.2019.02.010_bb0950","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/41567","article-title":"Absence of opiate rewarding effects in mice lacking dopamine D2 receptors","volume":"388","author":"Maldonado","year":"1997","journal-title":"Nature"},{"issue":"7398","key":"10.1016\/j.pnpbp.2019.02.010_bb0955","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the micro-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb0960","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb0965","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bph.12627","article-title":"Different mechanisms of homologous and heterologous mu-opioid receptor phosphorylation","volume":"172","author":"Mann","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"31","key":"10.1016\/j.pnpbp.2019.02.010_bb0970","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"\u03ba-Opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"2003","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.02.010_bb0975","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2009.01.019","article-title":"Pathways between nonmedical opioid use\/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"103","author":"Martins","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb0980","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1017\/S0033291711002145","article-title":"Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions","volume":"42","author":"Martins","year":"2011","journal-title":"Psychol. Med."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.02.010_bb0985","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pain.2004.04.020","article-title":"Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses","volume":"110","author":"Martucci","year":"2004","journal-title":"Pain"},{"issue":"47","key":"10.1016\/j.pnpbp.2019.02.010_bb0990","doi-asserted-by":"crossref","first-page":"12183","DOI":"10.1523\/JNEUROSCI.2326-08.2008","article-title":"A novel G\u03b2\u03b3-subunit inhibitor selectively modulates mu-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence","volume":"28","author":"Mathews","year":"2008","journal-title":"J. Neurosci."},{"issue":"42","key":"10.1016\/j.pnpbp.2019.02.010_bb0995","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.2174\/138161281942140105161733","article-title":"Microglia activation precedes the anti-opioid BDNF and NMDA receptor mechanisms underlying morphine analgesic tolerance","volume":"19","author":"Matsushita","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"6603","key":"10.1016\/j.pnpbp.2019.02.010_bb1000","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1005","first-page":"22","article-title":"Opioid receptors","volume":"5","author":"McDonald","year":"2005","journal-title":"BJA Educ."},{"issue":"13","key":"10.1016\/j.pnpbp.2019.02.010_bb1010","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1015","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/j.1471-4159.2008.05745.x","article-title":"Kappa opioids promote the proliferation of astrocytes via G\u03b2\u03b3 and \u03b2-arrestin 2-dependent MAPK-mediated pathways","volume":"107","author":"McLennan","year":"2008","journal-title":"J. Neurochem."},{"issue":"25","key":"10.1016\/j.pnpbp.2019.02.010_bb1020","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1000751107","article-title":"Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling","volume":"107","author":"Melief","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1025","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Merrer","year":"2009","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.genhosppsych.2012.06.018","article-title":"Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients","volume":"34","author":"Merrill","year":"2012","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.02.010_bb1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078258","article-title":"Initial D2 dopamine receptor sensitivity predicts cocaine sensitivity and reward in rats","volume":"8","author":"Merritt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1040","series-title":"Psychopharmacology: Drugs, the Brain, and Behavior","author":"Meyer","year":"2013"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0304-3959(86)90158-2","article-title":"Multiple opioid systems and pain","volume":"27","author":"Millan","year":"1986","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0165-6147(90)90321-X","article-title":"Kappa-opioid receptors and analgesia","volume":"11","author":"Millan","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"issue":"22","key":"10.1016\/j.pnpbp.2019.02.010_bb5000","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0024-3205(99)00148-4","article-title":"Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans","volume":"64","author":"Monory","year":"1999","journal-title":"Life Sci."},{"issue":"Pt A","key":"10.1016\/j.pnpbp.2019.02.010_bb1055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2016.06.048","article-title":"The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception","volume":"1648","author":"Moon","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.pa.20.040180.000501","article-title":"Structure-activity relationships of enkephalin-like peptides","volume":"20","author":"Morley","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00432213","article-title":"Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning","volume":"86","author":"Mucha","year":"1985","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.02.010_bb1070","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/sj.npp.1301007","article-title":"Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse","volume":"31","author":"Narita","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1196\/annals.1441.032","article-title":"Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine","volume":"1141","author":"Narita","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1080","series-title":"Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use","author":"National Academies of Sciences Engineering & Medicine","year":"2017"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1085","author":"National Center of Biotechnology Information"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.02.010_bb1090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.tips.2018.08.007","article-title":"Abuse potential of biased mu opioid receptor agonists","volume":"39","author":"Negus","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.pnpbp.2019.02.010_bb1095","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0024-3205(02)01496-0","article-title":"Role of benzodiazepine-GABAA receptor complex in attenuation of U-50,488H-induced analgesia and inhibition of tolerance to its analgesia by ginseng total saponin in mice","volume":"70","author":"Nemmani","year":"2002","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajmg.b.10005","article-title":"D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes","volume":"116b","author":"Noble","year":"2003","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0306-9877(94)90127-9","article-title":"D2 dopamine receptor gene and cigarette smoking: a reward gene?","volume":"42","author":"Noble","year":"1994","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01675349","article-title":"Dopaminergic neurons: effect of acute and chronic morphine administration on single cell activity and transmitter metabolism","volume":"42","author":"Nowycky","year":"1978","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0026-895X(25)13194-5","article-title":"The interaction between D-2 dopamine receptors and GTP-binding proteins","volume":"33","author":"Ohara","year":"1988","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/cells3010152","article-title":"Molecular perspectives for mu\/delta opioid receptor heteromers as distinct, functional receptors","volume":"3","author":"Ong","year":"2014","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","article-title":"Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide","volume":"47","author":"Osborne","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/clpt.1993.177","article-title":"CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone","volume":"54","author":"Otton","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb1135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0192-0561(00)00023-0","article-title":"Pharmacokinetics and cytokine production in heroin and morphine-treated mice","volume":"22","author":"Pacifici","year":"2000","journal-title":"Int. J. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-6147(98)01169-9","article-title":"mu-Opposing actions of the kappa-opioid receptor","volume":"19","author":"Pan","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"issue":"6649","key":"10.1016\/j.pnpbp.2019.02.010_bb1145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/38730","article-title":"Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor","volume":"389","author":"Pan","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/mol.56.2.396","article-title":"Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms","volume":"56","author":"Pan","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2019.02.010_bb1155","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0014-5793(00)01095-4","article-title":"Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F","volume":"466","author":"Pan","year":"2000","journal-title":"FEBS Lett."},{"issue":"24","key":"10.1016\/j.pnpbp.2019.02.010_bb1160","doi-asserted-by":"crossref","first-page":"14084","DOI":"10.1073\/pnas.241296098","article-title":"Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene","volume":"98","author":"Pan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1165","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuropharm.2004.07.004","article-title":"Multiple opiate receptors: D\u00e9j\u00e0 vu all over again","volume":"47","author":"Pasternak","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1170","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.apha.2017.09.006","article-title":"Mu opioid pharmacology: 40 years to the promised land","author":"Pasternak","year":"2018"},{"issue":"26","key":"10.1016\/j.pnpbp.2019.02.010_bb1175","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/0024-3205(87)90431-0","article-title":"Morphine-6-glucuronide, a potent mu agonist","volume":"41","author":"Pasternak","year":"1987","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1189\/jlb.68.5.723","article-title":"Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages","volume":"68","author":"Peng","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"17","key":"10.1016\/j.pnpbp.2019.02.010_bb1185","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1016\/j.bmc.2009.07.007","article-title":"Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways","volume":"17","author":"Peng","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb8000","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Pract."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3565(25)22683-0","article-title":"Diuretic actions in man of a selective kappa opioid agonist: U-62,066E","volume":"240","author":"Peters","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4765","key":"10.1016\/j.pnpbp.2019.02.010_bb1195","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mcn.2015.12.013","article-title":"Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine","volume":"71","author":"Pilat","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1205","article-title":"Alternative splicing of the delta-opioid receptor gene suggests existence of new functional isoforms","author":"Piltonen","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"25\u201326","key":"10.1016\/j.pnpbp.2019.02.010_bb1210","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.lfs.2013.09.016","article-title":"Novel fentanyl-based dual mu\/delta-opioid agonists for the treatment of acute and chronic pain","volume":"93","author":"Podolsky","year":"2013","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.pnpbp.2019.02.010_bb1215","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1021\/jm00089a001","article-title":"The role of concepts in structure-activity relationship studies of opioid ligands","volume":"35","author":"Portoghese","year":"1992","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1220","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2012.02075.x","article-title":"Ligand-directed signalling within the opioid receptor family","volume":"167","author":"Pradhan","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2019.02.010_bb1225","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1523\/JNEUROSCI.4124-15.2016","article-title":"Agonist-specific recruitment of arrestin isoforms differentially modify delta opioid receptor function","volume":"36","author":"Pradhan","year":"2016","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1230","first-page":"109","article-title":"Oxymorphone: a review","volume":"14","author":"Prommer","year":"2006","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018097","article-title":"Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor","volume":"6","author":"Radl","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1240","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-3-642-41199-1_22","article-title":"\u03b2-Arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia","volume":"219","author":"Raehal","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1245","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1250","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/ALN.0b013e31823940c0","article-title":"Case scenario opioid association with serotonin syndrome","volume":"115","author":"Rastogi","year":"2011","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1255","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0091-3057(83)90094-1","article-title":"Effects of mu- and kappa-opioid receptor agonists on urinary output in mice","volume":"19","author":"Rathbun","year":"1983","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"19","key":"10.1016\/j.pnpbp.2019.02.010_bb1260","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1265","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1073\/pnas.0409534102","article-title":"Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor","volume":"102","author":"Ren","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1270","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bph.14105","article-title":"Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome","volume":"175","author":"Rickli","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1275","series-title":"Neuropathology of Drug Addictions and Substance Misuse","first-page":"375","article-title":"Weak opioid analgesics abuse and addiction: a comparison of the pharmacology and pharmacoepidemiology of codeine, dihydrocodeine, and tramadol","author":"Roussin","year":"2016"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1280","series-title":"The Opiate Receptors","first-page":"407","article-title":"Opioid receptor dimerization","author":"Rozenfeld","year":"2011"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0169-328X(95)00165-O","article-title":"Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA","volume":"34","author":"Ruzicka","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2019.02.010_bb1290","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliat. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1295","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0304-3959(97)00055-9","article-title":"Effects of tramadol on immune responses and nociceptive thresholds in mice","volume":"72","author":"Sacerdote","year":"1997","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1300","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/00000539-200006000-00028","article-title":"The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients","volume":"90","author":"Sacerdote","year":"2000","journal-title":"Anesth. Analg."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1305","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbi.2007.12.013","article-title":"Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","volume":"22","author":"Sacerdote","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1310","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/157015912803217314","article-title":"Antidepressant-like effects of delta opioid receptor agonists in animal models","volume":"10","author":"Saitoh","year":"2012","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2019.02.010_bb1315","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1139\/y89-154","article-title":"The 1988 Merck Frosst Award.: the role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies","volume":"67","author":"Sawynok","year":"1989","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1320","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.cell.2009.04.019","article-title":"Dissociation of the opioid receptor mechanisms that control mechanical and heat pain","volume":"137","author":"Scherrer","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1325","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11606-013-2648-1","article-title":"Prescription opioid analgesics increase the risk of depression","volume":"29","author":"Scherrer","year":"2014","journal-title":"J. Gen. Intern. Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1330","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.3999","article-title":"New depression diagnosis following prescription of codeine, hydrocodone or oxycodone","volume":"25","author":"Scherrer","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1370\/afm.1885","article-title":"Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations","volume":"14","author":"Scherrer","year":"2016","journal-title":"Ann. Fam. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1340","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpain.2015.12.012","article-title":"Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients","volume":"17","author":"Scherrer","year":"2016","journal-title":"J. Pain"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1345","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1073\/pnas.0708862105","article-title":"Agonist-directed signaling of the serotonin 2A receptor depends on \u03b2-arrestin-2 interactions in vivo","volume":"105","author":"Schmid","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1350","first-page":"10","article-title":"Development of 5-substituted N-methylmorphinan-6-ones as potent opioid analgesics with improved side-effect profile","volume":"2012","author":"Schmidhammer","year":"2012","journal-title":"Int. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1355","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0022-3565(25)32472-9","article-title":"Pharmacological characterization of the epsilon-opiate receptor","volume":"216","author":"Schulz","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"16","key":"10.1016\/j.pnpbp.2019.02.010_bb1360","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/sj.emboj.7600334","article-title":"Morphine induces terminal mu-opioid receptor desensitization by sustained phosphorylation of serine-375","volume":"23","author":"Schulz","year":"2004","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb1365","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/15563650701668625","article-title":"Dextromethorphan-induced serotonin syndrome","volume":"46","author":"Schwartz","year":"2008","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1370","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-6147(97)01166-8","article-title":"G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways","volume":"19","author":"Selbie","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb1375","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/S0021-9258(18)61275-X","article-title":"The D2-dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin-sensitive guanine nucleotide binding protein","volume":"262","author":"Senogles","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1380","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1124\/jpet.105.091447","article-title":"Delta opioid receptors stimulate Akt-dependent phosphorylation of c-jun in T cells","volume":"316","author":"Shahabi","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1385","doi-asserted-by":"crossref","first-page":"562","DOI":"10.12659\/AJCR.892264","article-title":"Transient serotonin syndrome caused by concurrent use of tramadol and selective serotonin reuptake inhibitor","volume":"15","author":"Shakoor","year":"2014","journal-title":"Am. J. Case Rep."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000078444","article-title":"Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study","volume":"11","author":"Shavit","year":"2004","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.02.010_bb1395","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pain.2005.02.003","article-title":"Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance","volume":"115","author":"Shavit","year":"2005","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.02.010_bb1400","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tips.2011.05.002","article-title":"\u03b2-arrestin-mediated receptor trafficking and signal transduction","volume":"32","author":"Shenoy","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1405","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1074\/jbc.M506576200","article-title":"\u03b2-Arrestin-dependent, G protein-independent ERK1\/2 activation by the \u03b22 adrenergic receptor","volume":"281","author":"Shenoy","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1410","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1615\/CritRevNeurobiol.v12.i4.10","article-title":"The neurobiology of opiate reinforcement","volume":"12","author":"Shippenberg","year":"1998","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1415","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.iy.06.040188.001251","article-title":"Opioid peptides and opioid receptors in cells of the immune system","volume":"6","author":"Sibinga","year":"1988","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-6147(92)90025-2","article-title":"Molecular biology of dopamine receptors","volume":"13","author":"Sibley","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.pnpbp.2019.02.010_bb1425","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1073\/pnas.92.15.7006","article-title":"kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system","volume":"92","author":"Simonin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1430","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/glia.22460","article-title":"Astrocytes are a neural target of morphine action via glucocorticoid receptor-dependent signaling","volume":"61","author":"Slezak","year":"2013","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1435","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-3565(25)32986-1","article-title":"Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine","volume":"220","author":"Slizgi","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.02.010_bb1440","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1445","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: from simple switches to allosteric microprocessors","volume":"17","author":"Smith","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.pnpbp.2019.02.010_bb1450","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00018-008-8006-5","article-title":"G protein \u03b2\u03b3 subunits: central mediators of G protein-coupled receptor signaling","volume":"65","author":"Smrcka","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1455","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.phrs.2009.04.002","article-title":"Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain","volume":"60","author":"Sotgiu","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1460","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0898-6568(96)00174-X","article-title":"G Proteins and opioid receptor-mediated signalling","volume":"9","author":"Standifer","year":"1997","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1465","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.yhbeh.2004.05.007","article-title":"Acute progesterone can recruit sex-specific neurochemical mechanisms mediating swim stress-induced and kappa-opioid analgesia in mice","volume":"46","author":"Sternberg","year":"2004","journal-title":"Horm. Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1470","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0024-3205(90)90041-O","article-title":"Opioid-dependent growth of glial cultures: suppression of astrocyte DNA synthesis by met-enkephalin","volume":"46","author":"Stiene-Martin","year":"1990","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1475","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jnr.490290415","article-title":"Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro","volume":"29","author":"Stiene-Martin","year":"1991","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(93)90628-X","article-title":"Morphine suppresses DNA synthesis in cultured murine astrocytes from cortex, hippocampus and striatum","volume":"157","author":"Stiene-Martin","year":"1993","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-3806(91)90149-D","article-title":"Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation","volume":"60","author":"Stiene-Martin","year":"1991","journal-title":"Brain Res. Dev. Brain Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1490","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/glia.1097","article-title":"Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo","volume":"36","author":"Stiene-Martin","year":"2001","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1495","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2005.03.009","article-title":"Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"80","author":"Stinson","year":"2005","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1500","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.neuron.2018.04.021","article-title":"A genetically encoded biosensor reveals location bias of opioid drug action","volume":"98","author":"Stoeber","year":"2018","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2019.02.010_bb1505","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(00)01573-1","article-title":"d-Morphine, but not l-morphine, has low micromolar affinity for the non-competitive N-methyl-D-aspartate site in rat forebrain. Possible clinical implications for the management of neuropathic pain","volume":"295","author":"Stringer","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1510","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1046\/j.1471-4159.2001.00367.x","article-title":"Selective inhibition of \u03b22-adrenergic receptor-mediated cAMP generation by activation of the P2Y2 receptor in mouse pineal gland tumor cells","volume":"77","author":"Suh","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1515","series-title":"xPharm: The Comprehensive Pharmacology Reference","first-page":"1","article-title":"Drug absorption","author":"Sultatos","year":"2007"},{"issue":"7","key":"10.1016\/j.pnpbp.2019.02.010_bb1520","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/1049909112469823","article-title":"Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain","volume":"30","author":"Suzuki","year":"2013","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1525","series-title":"Progress in Drug Research","first-page":"167","article-title":"U-50,488 and the \u043a receptor: a personalized account covering the period 1973 to 1990","author":"Szmuszkovicz","year":"1999"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1530","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3565(25)21011-4","article-title":"Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays","volume":"246","author":"Takemori","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb1535","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1074\/jbc.M806742200","article-title":"p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous \u03bc-opioid and \u03b12A-adrenergic receptors in neurons","volume":"284","author":"Tan","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1540","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00428193","article-title":"Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys","volume":"85","author":"Tang","year":"1985","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1545","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/bph.12810","article-title":"Anti-nociception mediated by a kappa opioid receptor agonist is blocked by a delta receptor agonist","volume":"172","author":"Taylor","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1550","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bjp.0705595","article-title":"G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal","volume":"141","author":"Terman","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1555","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/jm000427g","article-title":"Factors influencing agonist potency and selectivity for the opioid \u03b4 receptor are revealed in structure\u2212activity relationship studies of the 4-[(N-Substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides","volume":"44","author":"Thomas","year":"2001","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1560","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cell.2016.07.004","article-title":"GPCR-G protein-\u03b2-arrestin super-complex mediates sustained G protein signaling","volume":"166","author":"Thomsen","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1565","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb1570","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1211\/jpp.59.8.0008","article-title":"Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice","volume":"59","author":"Tokuyama","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1575","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3565(25)24991-6","article-title":"U50,488, a highly selective kappa opioid: anticonvulsant profile in rats","volume":"237","author":"Tortella","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2019.02.010_bb1580","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2011.09.169","article-title":"The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain","volume":"671","author":"Tsukahara-Ohsumi","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1590","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/B978-0-12-411512-5.00019-1","article-title":"Neuropeptide regulation of the locus coeruleus and opiate-induced plasticity of stress responses","volume":"68","author":"Van Bockstaele","year":"2013","journal-title":"Adv. Pharmacol."},{"issue":"Suppl. 10","key":"10.1016\/j.pnpbp.2019.02.010_bb1595","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/AJP.0b013e3181c49e3a","article-title":"Delta and kappa opioid receptors as suitable drug targets for pain","volume":"26","author":"Vanderah","year":"2010","journal-title":"Clin. J. Pain"},{"issue":"11","key":"10.1016\/j.pnpbp.2019.02.010_bb1600","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/acschemneuro.5b00153","article-title":"Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior","volume":"6","author":"Varadi","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1605","first-page":"514","article-title":"Is the WHO analgesic ladder still valid?: twenty-four years of experience","volume":"56","author":"Vargas-Schaffer","year":"2010","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1610","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916667949","article-title":"Repeated activation of delta opioid receptors counteracts nerve injury-induced TNF-\u03b1 up-regulation in the sciatic nerve of rats with neuropathic pain: a possible correlation with delta opioid receptors-mediated antiallodinic effect","volume":"12","author":"Vicario","year":"2016","journal-title":"Mol. Pain"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb1615","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.biopsych.2010.08.002","article-title":"Opioid\u2013dopamine interactions: implications for substance use disorders and their treatment","volume":"68","author":"Volkow","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"13","key":"10.1016\/j.pnpbp.2019.02.010_bb1620","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.2011.401","article-title":"Characteristics of opioid prescriptions in 2009","volume":"305","author":"Volkow","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1625","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"Defacto long-term opioid therapy for non-cancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin. J. Pain"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1630","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0022-3565(25)11010-0","article-title":"U-54494A: a unique anticonvulsant related to kappa opioid agonists","volume":"243","author":"VonVoigtlander","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1635","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1527-3458.2003.tb00248.x","article-title":"A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist","volume":"9","author":"Wadenberg","year":"2003","journal-title":"CNS Drug Rev."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2019.02.010_bb1640","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2010.10.083","article-title":"Buprenorphine-induced hyperalgesia in the rat","volume":"651","author":"Wala","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1645","article-title":"An unusual case of serotonin syndrome with oxycodone and citalopram","volume":"261787","author":"Walter","year":"2012","journal-title":"Case Rep Oncol Med."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb1650","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","article-title":"Immunosuppression associated with chronic inflammation in the tumor microenvironment","volume":"36","author":"Wang","year":"2015","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1655","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1189\/jlb.71.5.782","article-title":"The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor","volume":"71","author":"Wang","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1660","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1471-4159.2005.03055.x","article-title":"Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases","volume":"93","author":"Wang","year":"2005","journal-title":"J. Neurochem."},{"issue":"29","key":"10.1016\/j.pnpbp.2019.02.010_bb1665","doi-asserted-by":"crossref","first-page":"13117","DOI":"10.1073\/pnas.1008382107","article-title":"Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.pnpbp.2019.02.010_bb1670","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1675","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuron.2018.03.002","article-title":"Functional divergence of delta and mu opioid receptor organization in CNS pain circuits","volume":"98","author":"Wang","year":"2018","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1680","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1073\/pnas.88.5.1859","article-title":"D1 and D2 dopamine receptor mRNA in rat brain","volume":"88","author":"Weiner","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1685","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1046\/j.1471-4159.1998.70052139.x","article-title":"Activation of microtubule-associated protein kinase (ERK) and p70 S6 kinase by D2 dopamine receptors","volume":"70","author":"Welsh","year":"1998","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.pnpbp.2019.02.010_bb7000","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bmcl.2009.02.078","article-title":"Syntheses of novel high affinity ligands for opioid receptors","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1690","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0896-6273(01)80032-5","article-title":"Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction","volume":"23","author":"Whistler","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1695","first-page":"1","article-title":"Cancer pain relief and palliative care. Report of a WHO Expert Committee","volume":"804","author":"WHO","year":"1990","journal-title":"World Health Organ. Tech. Rep. Ser."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1700","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.02.010_bb1705","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.78.10.6181","article-title":"Classification of multiple morphine and enkephalin binding sites in the central nervous system","volume":"78","author":"Wolozin","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.02.010_bb1710","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0196-9781(83)90003-7","article-title":"Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences","volume":"4","author":"Wood","year":"1983","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1715","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(25)32360-8","article-title":"Actions of mu, kappa, sigma, delta and agonist\/antagonist opiates on striatal dopaminergic function","volume":"215","author":"Wood","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2019.02.010_bb1720","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3940(79)96112-3","article-title":"Specificity of opioids towards the mu-, delta- and epsilon-opiate receptors","volume":"15","author":"Wuster","year":"1979","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.02.010_bb1725","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pain.2006.03.011","article-title":"The role of tumor necrosis factor-alpha in the neuropathic pain induced by Lumbar 5 ventral root transection in rat","volume":"123","author":"Xu","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1730","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8069-7-9","article-title":"Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1","volume":"7","author":"Xu","year":"2011","journal-title":"Mol. Pain"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1735","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/syn.21727","article-title":"Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P","volume":"68","author":"Xu","year":"2013","journal-title":"Synapse"},{"issue":"23","key":"10.1016\/j.pnpbp.2019.02.010_bb1740","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.lfs.2013.04.006","article-title":"PKA and ERK1\/2 are involved in dopamine D(1) receptor-induced heterologous desensitization of the delta opioid receptor","volume":"92","author":"Xu","year":"2013","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2019.02.010_bb1745","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1172\/JCI88760","article-title":"Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine","volume":"127","author":"Xu","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1750","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(89)90495-0","article-title":"Mechanism of diuretic action of U-62,066E, a \u03ba opioid receptor agonist","volume":"160","author":"Yamada","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1755","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12929-015-0186-3","article-title":"Effects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice","volume":"22","author":"Yang","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.pnpbp.2019.02.010_bb1760","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.phrs.2016.05.034","article-title":"Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice","volume":"111","author":"Yang","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.pnpbp.2019.02.010_bb1765","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/cn300049m","article-title":"Clinically employed opioid analgesics produce antinociception via mu-delta opioid receptor heteromers in Rhesus monkeys","volume":"3","author":"Yekkirala","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1770","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14712\/fb2004050010024","article-title":"The alterations of immunological reactivity in heroin addicts and their normalization in patients maintained on methadone","volume":"50","author":"Zajicova","year":"2004","journal-title":"Folia Biol. (Praha)"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1775","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2005.04.006","article-title":"Involvement of the ventral tegmental area (VTA) in morphine-induced memory retention in morphine-sensitized rats","volume":"163","author":"Zarrindast","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.pnpbp.2019.02.010_bb1780","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1073\/pnas.95.12.7157","article-title":"Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness","volume":"95","author":"Zhang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.02.010_bb1785","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbi.2011.09.017","article-title":"Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference","volume":"26","author":"Zhang","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.pnpbp.2019.02.010_bb1790","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/mol.107.039842","article-title":"Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) translocate to nucleus in contrast to G protein-dependent ERK activation","volume":"73","author":"Zheng","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.02.010_bb1795","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FTD.0b013e31815c16f5","article-title":"Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring","volume":"29","author":"Zhou","year":"2007","journal-title":"Ther. Drug Monit."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618305475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618305475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:52:20Z","timestamp":1759521140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584618305475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":363,"alternative-id":["S0278584618305475"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.02.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Members of the same pharmacological family are not alike: Different opioids, different consequences, hope for the opioid crisis?","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}